Insider Transactions in Q3 2025 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 04
2025
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
36,130
-18.31%
|
$578,080
$16.16 P/Share
|
Sep 02
2025
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-9.07%
|
$150,000
$15.64 P/Share
|
Sep 02
2025
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.32%
|
-
|
Aug 21
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
2,438
-2.27%
|
$36,570
$15.57 P/Share
|
Aug 19
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
1,750
-1.61%
|
$28,000
$16.16 P/Share
|
Aug 08
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
3,847
-3.41%
|
$53,858
$14.03 P/Share
|
Aug 04
2025
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
6,330
-3.11%
|
$88,620
$14.33 P/Share
|
Aug 04
2025
|
Latha Vairavan SVP Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
89
-0.14%
|
$1,246
$14.33 P/Share
|
Aug 04
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
2,622
-2.27%
|
$36,708
$14.33 P/Share
|
Aug 04
2025
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
11,547
-1.26%
|
$161,658
$14.33 P/Share
|
Aug 01
2025
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-4.74%
|
$140,000
$14.3 P/Share
|
Aug 01
2025
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.52%
|
-
|
Jul 14
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
5,750
-4.74%
|
$86,250
$15.07 P/Share
|
Jul 14
2025
|
Patrick Burnett Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,750
+4.53%
|
-
|
Jul 10
2025
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
23,000
-16.61%
|
$345,000
$15.05 P/Share
|
Jul 10
2025
|
Patrick Burnett Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+14.24%
|
-
|
Jul 01
2025
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
9,208
-8.42%
|
$119,704
$13.84 P/Share
|